Mashup Score: 2
CheckRareThe U.S. Food and Drug Administration (FDA) has approved Oxbryta (voxelotor) to treat persons, 12 years and older, with sickle cell
Mashup Score: 2
CheckRareThe U.S. Food and Drug Administration (FDA) has approved Oxbryta (voxelotor) to treat persons, 12 years and older, with sickle cell
The U.S. Food and Drug Administration has approved Oxbryta (voxelotor) to treat persons, 12 years and older, with sickle cell disease. @GBT_news @US_FDA @SickleCellUK Global Blood Therapeutics https://t.co/IkBlKqLw4V - view on twitter